Stock Scorecard
Stock Summary for Inovio Pharmaceuticals Inc (INO) - $1.80 as of 3/28/2025 8:10:06 PM EST
Total Score
12 out of 30
Safety Score
32 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for INO
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for INO
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for INO
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for INO
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for INO (32 out of 100)
| Stock Price Rating (Max of 10) | 2 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 6 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for INO
Financial Details for INO
Company Overview |
|
|---|---|
| Ticker | INO |
| Company Name | Inovio Pharmaceuticals Inc |
| Country | USA |
| Description | Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA drugs to treat and protect people from diseases associated with the human papillomavirus (HPV), cancer, and infectious diseases. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 12/31/2024 |
| Next Earnings Date | 5/12/2025 |
Stock Price History |
|
| Last Day Price | 1.80 |
| Price 4 Years Ago | 59.88 |
| Last Day Price Updated | 3/28/2025 8:10:06 PM EST |
| Last Day Volume | 691,745 |
| Average Daily Volume | 735,627 |
| 52-Week High | 14.75 |
| 52-Week Low | 1.71 |
| Last Price to 52 Week Low | 5.26% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 64.12 |
| Sector PE | 40.10 |
| 5-Year Average PE | -31.63 |
| Free Cash Flow Ratio | 0.70 |
| Industry Free Cash Flow Ratio | 29.26 |
| Sector Free Cash Flow Ratio | 47.05 |
| Current Ratio Most Recent Quarter | 2.77 |
| Total Cash Per Share | 2.57 |
| Book Value Per Share Most Recent Quarter | 1.90 |
| Price to Book Ratio | 0.94 |
| Industry Price to Book Ratio | 5.12 |
| Sector Price to Book Ratio | 21.92 |
| Price to Sales Ratio Twelve Trailing Months | 296.36 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.27 |
| Sector Price to Sales Ratio Twelve Trailing Months | 27.78 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 36,667,200 |
| Market Capitalization | 66,000,960 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 1.52% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 20.62% |
| Reported EPS 12 Trailing Months | -3.97 |
| Reported EPS Past Year | -3.99 |
| Reported EPS Prior Year | -1.54 |
| Net Income Twelve Trailing Months | -107,254,126 |
| Net Income Past Year | -107,254,126 |
| Net Income Prior Year | -135,117,352 |
| Quarterly Revenue Growth YOY | 14.00% |
| 5-Year Revenue Growth | -44.44% |
| Operating Margin Twelve Trailing Months | -17,411.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 94,100,000 |
| Total Cash Past Year | 94,100,000 |
| Total Cash Prior Year | 145,300,000 |
| Net Cash Position Most Recent Quarter | 77,329,346 |
| Net Cash Position Past Year | 77,329,346 |
| Long Term Debt Past Year | 16,770,654 |
| Long Term Debt Prior Year | 16,770,654 |
| Total Debt Most Recent Quarter | 16,770,654 |
| Equity to Debt Ratio Past Year | 0.80 |
| Equity to Debt Ratio Most Recent Quarter | 0.80 |
| Total Stockholder Equity Past Year | 68,503,795 |
| Total Stockholder Equity Prior Year | 117,349,129 |
| Total Stockholder Equity Most Recent Quarter | 68,503,795 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -104,564,385 |
| Free Cash Flow Per Share Twelve Trailing Months | -2.85 |
| Free Cash Flow Past Year | -104,564,385 |
| Free Cash Flow Prior Year | -124,686,449 |
Options |
|
| Put/Call Ratio | 0.05 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.07 |
| MACD Signal | -0.04 |
| 20-Day Bollinger Lower Band | 0.68 |
| 20-Day Bollinger Middle Band | 2.46 |
| 20-Day Bollinger Upper Band | 4.23 |
| Beta | 0.92 |
| RSI | 34.72 |
| 50-Day SMA | 6.21 |
| 150-Day SMA | 11.32 |
| 200-Day SMA | 26.92 |
System |
|
| Modified | 3/27/2025 11:26:26 PM EST |